CLINICAL_TRIALS trial_result · 2024-05-30

Clinical Trial Update: Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients [Phase 4]

A Phase 4 trial studying metabolic phenotyping during stress hyperglycemia in cardiac surgery patients was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Emory University | Conditions: Stress Hyperglycemia | Phase 4 | Status: TERMINATED | Results posted: 2024-05-30